奥精医疗
(688613)
| 流通市值：24.95亿 | | | 总市值：24.95亿 |
| 流通股本：1.37亿 | | | 总股本：1.37亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 136,433,523.59 | 156,714,432.71 | 159,988,241.56 | 181,241,583.48 |
| 应收票据及应收账款 | 68,730,265.15 | 67,159,276.75 | 89,875,190.35 | 86,462,994.42 |
| 应收账款 | 68,730,265.15 | 67,159,276.75 | 89,875,190.35 | 86,462,994.42 |
| 预付款项 | 5,459,479.79 | 8,248,123.79 | 8,866,562.45 | 2,185,532.48 |
| 其他应收款合计 | 13,149,607.21 | 10,088,663.78 | 11,078,682.45 | 9,083,007.87 |
| 存货 | 93,901,737.38 | 54,577,004.67 | 40,091,918.6 | 34,574,582.89 |
| 其他流动资产 | 2,346,491.94 | 4,035,165.94 | 5,325,591.85 | 6,561,774.41 |
| 流动资产平衡项目 | 0.01 | 0 | 0 | 0 |
| 流动资产合计 | 1,221,187,518.2 | 1,196,396,879.83 | 1,213,005,706.58 | 1,217,398,344.06 |
| 非流动资产: | | | | |
| 投资性房地产 | 51,901,841.12 | 52,641,071.27 | 53,380,301.42 | 54,119,531.57 |
| 固定资产 | 169,818,946.28 | 173,505,417.88 | 173,210,905.93 | 176,879,811.37 |
| 在建工程 | 418,386.69 | 73,109.1 | 1,433,989.3 | 332,868.07 |
| 使用权资产 | 6,822,929.13 | 6,996,011.28 | 3,340,588.07 | 3,519,548.15 |
| 无形资产 | 24,889,819.44 | 25,356,633.73 | 22,260,950.78 | 22,512,674.02 |
| 开发支出 | - | - | 174,880 | - |
| 商誉 | 24,618,560.01 | 24,618,560.01 | 28,129,875.44 | 28,129,875.44 |
| 长期待摊费用 | 34,065,501.47 | 35,493,242.32 | 33,333,507.53 | 32,771,708.72 |
| 递延所得税资产 | 23,838,789.91 | 23,838,789.91 | 21,733,836.44 | 21,733,836.44 |
| 其他非流动资产 | - | 243,622.28 | 4,581,971.13 | 5,096,256.07 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 336,374,774.05 | 342,766,457.78 | 341,580,806.04 | 345,096,109.85 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,557,562,292.25 | 1,539,163,337.61 | 1,554,586,512.62 | 1,562,494,453.91 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 41,165,811.29 | 12,952,487.19 | 8,284,627.16 | 11,097,763.51 |
| 其中：应付票据 | - | - | - | 1,016,523.88 |
| 应付账款 | 41,165,811.29 | 12,952,487.19 | 8,284,627.16 | 10,081,239.63 |
| 合同负债 | 9,097,215.97 | 5,106,825.69 | 15,933,780.76 | 12,917,958.79 |
| 应付职工薪酬 | 5,072,698.58 | 17,436,116.31 | 4,852,756.23 | 4,286,210.19 |
| 应交税费 | 4,620,453.61 | 6,147,233.23 | 2,009,739.69 | 2,141,672.84 |
| 其他应付款合计 | 2,880,869.88 | 3,844,038.52 | 11,601,717.6 | 11,979,474.71 |
| 一年内到期的非流动负债 | 3,249,783.75 | 6,620,935.89 | 5,234,621.99 | 5,234,621.99 |
| 其他流动负债 | 272,916.48 | 153,204.77 | 416,133.09 | 379,631.04 |
| 流动负债平衡项目 | 0.01 | 0 | 0 | 0 |
| 流动负债合计 | 66,359,749.57 | 52,260,841.6 | 48,333,376.52 | 48,037,333.07 |
| 非流动负债: | | | | |
| 长期借款 | 41,452,173.33 | 40,752,173.33 | 41,752,173.33 | 43,052,173.33 |
| 租赁负债 | 5,729,119.08 | 4,980,791.14 | 2,592,689.89 | 2,748,547.14 |
| 预计负债 | 11,234.32 | - | - | - |
| 递延收益 | 20,941,503.25 | 20,941,503.25 | 22,671,742.25 | 22,351,742.25 |
| 递延所得税负债 | 274,426.24 | 264,904.64 | 1,642,424.89 | 1,634,785.39 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 68,408,456.22 | 66,939,372.36 | 68,659,030.36 | 69,787,248.11 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 134,768,205.79 | 119,200,213.96 | 116,992,406.88 | 117,824,581.18 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 135,551,584 | 135,551,584 | 135,551,584 | 135,551,584 |
| 资本公积 | 969,333,074.99 | 966,590,272.49 | 967,573,821.7 | 960,792,058.42 |
| 其他综合收益 | -12,905.79 | -293,775.12 | 25,125.05 | -3,814.7 |
| 盈余公积 | 46,886,146.23 | 46,886,146.23 | 45,832,496.59 | 45,832,496.59 |
| 未分配利润 | 255,181,673.73 | 254,140,155.97 | 272,744,210.15 | 285,210,988.42 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,406,939,573.16 | 1,402,874,383.57 | 1,421,727,237.49 | 1,427,383,312.73 |
| 少数股东权益 | 15,854,513.29 | 17,088,740.08 | 15,866,868.25 | 17,286,560 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,422,794,086.45 | 1,419,963,123.65 | 1,437,594,105.74 | 1,444,669,872.73 |
| 负债和股东权益合计 | 1,557,562,292.25 | 1,539,163,337.61 | 1,554,586,512.62 | 1,562,494,453.91 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-29 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |